
    
      The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of
      iStent inject in eyes of subjects with primary open-angle glaucoma previously on two
      anti-glaucoma medications. Outcomes will be evaluated at 12 and 24 months.
    
  